Humana Inc. (0J6Z.L)
USD 257.72
(-0.95%)
USD 257.72
(-0.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.48 Billion USD | -11.3% |
| 2022 | 2.8 Billion USD | -4.33% |
| 2021 | 2.93 Billion USD | -12.89% |
| 2020 | 3.36 Billion USD | 24.38% |
| 2019 | 2.7 Billion USD | 60.84% |
| 2018 | 1.68 Billion USD | -31.25% |
| 2017 | 2.44 Billion USD | 298.7% |
| 2016 | 614 Million USD | -51.88% |
| 2015 | 1.27 Billion USD | 11.25% |
| 2014 | 1.14 Billion USD | -6.82% |
| 2013 | 1.23 Billion USD | 0.74% |
| 2012 | 1.22 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 480 Million USD | -29.31% |
| 2024 Q1 | 741 Million USD | 236.97% |
| 2024 Q2 | 679 Million USD | -8.37% |
| 2023 Q2 | 959 Million USD | -22.6% |
| 2023 Q1 | 1.23 Billion USD | 8360.0% |
| 2023 FY | 2.48 Billion USD | -11.3% |
| 2023 Q3 | 832 Million USD | -13.24% |
| 2023 Q4 | -541 Million USD | -165.02% |
| 2022 Q4 | -15 Million USD | -101.26% |
| 2022 Q2 | 696 Million USD | -25.16% |
| 2022 Q1 | 930 Million USD | 6742.86% |
| 2022 FY | 2.8 Billion USD | -4.33% |
| 2022 Q3 | 1.19 Billion USD | 71.7% |
| 2021 Q2 | 588 Million USD | -28.99% |
| 2021 Q4 | -14 Million USD | -100.91% |
| 2021 FY | 2.93 Billion USD | -12.89% |
| 2021 Q1 | 828 Million USD | 402.19% |
| 2021 Q3 | 1.53 Billion USD | 160.37% |
| 2020 Q1 | 473 Million USD | -7.62% |
| 2020 Q3 | 1.34 Billion USD | -26.7% |
| 2020 Q4 | -274 Million USD | -120.45% |
| 2020 FY | 3.36 Billion USD | 24.38% |
| 2020 Q2 | 1.82 Billion USD | 286.47% |
| 2019 FY | 2.7 Billion USD | 60.84% |
| 2019 Q4 | 512 Million USD | -25.69% |
| 2019 Q3 | 689 Million USD | -26.7% |
| 2019 Q2 | 940 Million USD | 66.08% |
| 2019 Q1 | 566 Million USD | 59.44% |
| 2018 Q4 | 355 Million USD | -44.88% |
| 2018 Q2 | 193 Million USD | -60.69% |
| 2018 FY | 1.68 Billion USD | -31.25% |
| 2018 Q1 | 491 Million USD | 166.85% |
| 2018 Q3 | 644 Million USD | 233.68% |
| 2017 FY | 2.44 Billion USD | 298.7% |
| 2017 Q3 | 499 Million USD | -23.23% |
| 2017 Q1 | 1.11 Billion USD | 378.05% |
| 2017 Q4 | 184 Million USD | -63.13% |
| 2017 Q2 | 650 Million USD | -41.7% |
| 2016 Q3 | 450 Million USD | 44.69% |
| 2016 FY | 614 Million USD | -51.88% |
| 2016 Q4 | -401 Million USD | -189.11% |
| 2016 Q2 | 311 Million USD | 22.44% |
| 2016 Q1 | 254 Million USD | 151.49% |
| 2015 Q1 | 430 Million USD | 196.55% |
| 2015 FY | 1.27 Billion USD | 11.25% |
| 2015 Q4 | 101 Million USD | -67.83% |
| 2015 Q3 | 314 Million USD | -27.15% |
| 2015 Q2 | 431 Million USD | 0.23% |
| 2014 Q4 | 145 Million USD | -50.0% |
| 2014 Q2 | 344 Million USD | -6.52% |
| 2014 FY | 1.14 Billion USD | -6.82% |
| 2014 Q1 | 368 Million USD | 1326.67% |
| 2014 Q3 | 290 Million USD | -15.7% |
| 2013 Q1 | 473 Million USD | 146.35% |
| 2013 Q2 | 420 Million USD | -11.21% |
| 2013 Q3 | 368 Million USD | -12.38% |
| 2013 Q4 | -30 Million USD | -108.15% |
| 2013 FY | 1.23 Billion USD | 0.74% |
| 2012 Q3 | 426 Million USD | 19.66% |
| 2012 FY | 1.22 Billion USD | 0.0% |
| 2012 Q2 | 356 Million USD | 0.0% |
| 2012 Q4 | 192 Million USD | -54.93% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 1918.315% |
| Accuray Incorporated | -15.54 Million USD | 16111.579% |
| Align Technology, Inc. | 445.05 Million USD | -459.259% |
| Elevance Health Inc. | 5.98 Billion USD | 58.427% |
| AxoGen, Inc. | -21.71 Million USD | 11561.595% |
| Boston Scientific Corporation | 1.59 Billion USD | -56.246% |
| CVS Health Corporation | 8.34 Billion USD | 70.17% |
| Cardinal Health, Inc. | 852 Million USD | -192.136% |
| Centene Corporation | 2.7 Billion USD | 7.883% |
| DaVita Inc. | 691.53 Million USD | -259.924% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 52.518% |
| Hologic, Inc. | 789.5 Million USD | -215.263% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -194.542% |
| Laboratory Corporation of America Holdings | 418 Million USD | -495.455% |
| Masimo Corporation | 81.5 Million USD | -2953.988% |
| McKesson Corporation | 3 Billion USD | 17.089% |
| Patterson Companies, Inc. | 185.93 Million USD | -1238.669% |
| Quest Diagnostics Incorporated | 854 Million USD | -191.452% |
| ResMed Inc. | 1.02 Billion USD | -143.792% |
| Henry Schein, Inc. | 416 Million USD | -498.317% |
| Teladoc Health, Inc. | -220.36 Million USD | 1229.474% |
| Universal Health Services, Inc. | 717.79 Million USD | -246.756% |
| Veeva Systems Inc. | 525.7 Million USD | -373.459% |
| Baxter International Inc. | 2.65 Billion USD | 6.288% |
| Becton, Dickinson and Company | 1.48 Billion USD | -67.722% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -38.432% |
| Danaher Corporation | 4.2 Billion USD | 40.738% |
| Stryker Corporation | 3.16 Billion USD | 21.359% |
| Medtronic plc | 3.67 Billion USD | 32.291% |